UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

Leukemia, 2016-05, Vol.30 (5), p.1018-1024

2016

Volltextzugriff (PDF)

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

Leukemia, 2018-02, Vol.32 (2), p.429-437

2018

Volltextzugriff (PDF)

Early detection of myeloproliferative neoplasms in a Danish general population study

Leukemia, 2021-09, Vol.35 (9), p.2706-2709

2021

Volltextzugriff (PDF)

COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon

Cytokine & growth factor reviews, 2021-08, Vol.60, p.28-45

2021

Volltextzugriff (PDF)

The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

Leukemia, 2016-12, Vol.30 (12), p.2413-2416

2016

Volltextzugriff (PDF)

Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study

Journal of internal medicine, 2016-06, Vol.279 (6), p.566-575

2016

Volltextzugriff (PDF)

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

Leukemia, 2017-02, Vol.31 (2), p.495-498

2017

Volltextzugriff (PDF)

Antibodies to calnexin and mutated calreticulin are common in human sera

Current research in translational medicine, 2023-04, Vol.71 (2), p.103380-103380, Article 103380

2023

Volltextzugriff (PDF)

Characterization of blood donors with high haemoglobin concentration

Vox sanguinis, 2013-02, Vol.104 (2), p.110-114

2013

Volltextzugriff (PDF)

Inheritance of the chronic myeloproliferative neoplasms. A systematic review

Clinical genetics, 2013-02, Vol.83 (2), p.99-107

2013

Volltextzugriff (PDF)

Distinguishing myelofibrosis from polycythemia vera and essential thrombocythemia: The utility of enumerating circulating stem cells with aberrant hMICL expression by flow cytometry

International journal of laboratory hematology, 2018-06, Vol.40 (3), p.320-325

2018

Volltextzugriff (PDF)

A unified definition of clinical resistance intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

Leukemia, 2007-02, Vol.21 (2), p.277-280

2007

Volltextzugriff (PDF)

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow

Leukemia, 2008-01, Vol.22 (1), p.194-195

2008

Volltextzugriff (PDF)

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES

HemaSphere, 2022-06, Vol.6, p.97-98

2022

Volltextzugriff (PDF)

Combination therapy with interferon and JAK1-2 inhibitor is feasible: Proof of concept with rapid reduction in JAK2V617F-allele burden in polycythemia vera

Leukemia research reports, 2014, Vol.3 (2), p.73-75

2014

Volltextzugriff (PDF)

Systemic adverse events following rituximab therapy in patients with Graves’ disease

Journal of endocrinological investigation, 2011-07, Vol.34 (7), p.e163-e167

2011

Volltextzugriff (PDF)

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Blood, 2005-10, Vol.106 (8), p.2849-2853

2005

Volltextzugriff (PDF)

Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders

British journal of haematology, 2000-07, Vol.110 (1), p.116-124

2000

Volltextzugriff (PDF)

FRI0113 Rheumatoid arthritis and eosinophilia: the risk of lymphoproliferative malignancies and solid cancers. a study based on the copenhagen primary care differential count (copdiff) database

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A408-A408

2013

Volltextzugriff (PDF)

Angiogenesis in pulmonary hypertension with myelofibrosis

Haematologica (Roma), 2008-06, Vol.93 (6), p.945-946

2008

Volltextzugriff (PDF)

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera

Annals of hematology, 2008-10, Vol.87 (10), p.847-850

2008

Volltextzugriff (PDF)

Corrigendum to “Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera” [Leuk. Res. Rep. 3 (2) (2014) 73–75]

Leukemia research reports, 2015, Vol.4 (1), p.31-31

2015

Volltextzugriff (PDF)

Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows

Haematologica (Roma), 2007-05, Vol.92 (5), p.597-604

2007

Volltextzugriff (PDF)

Echocardiographic signs of aortic valve dysfunction in patients with Philadelphia-negative myeloproliferative neoplasms

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

High JAK2V617F allele burden is associated with an increased burden of coronary artery calcification in MPNs

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

1 – 25 von 352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(211)
Science & Technology
(188)
Life Sciences & Biomedicine
(187)
Male
(142)
Female
(125)
Middle Aged
(117)
Adult
(105)
Biological And Medical Sciences
(86)
Aged
(84)
Hematology
(83)
Medical Sciences
(83)
Hematologic And Hematopoietic Diseases
(46)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(37)
Aged, 80 And Over
(34)
Neurosciences & Neurology
(33)
Neurosciences
(26)
Medicin Och Hälsovetenskap
(25)
Myelofibrosis
(24)
Oncology
(24)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(214)
Journals@Ovid
(204)
Electronic Journals Library
(172)
Wiley Online Library
(112)
IngentaConnect
(103)
Wiley Online Library
(84)
NUS Single-Journal Subscriptions
(61)
IngentaConnect Journals
(47)
Elsevier ScienceDirect Journals Collection
(42)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(33)
SAGE Journals
(31)
Oxford Journals
(26)
Oxford Journals 2020 Medicine
(25)
Taylor & Francis Journals
(24)
Taylor & Francis Online
(23)
Springer Journals
(17)
Nature Journals
(16)
Nexis Uni
(15)
Taylor & Francis
(10)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

Early detection of myeloproliferative neoplasms in a Danish general population study

COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon

The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

Antibodies to calnexin and mutated calreticulin are common in human sera

Characterization of blood donors with high haemoglobin concentration

Inheritance of the chronic myeloproliferative neoplasms. A systematic review

Distinguishing myelofibrosis from polycythemia vera and essential thrombocythemia: The utility of enumerating circulating stem cells with aberrant hMICL expression by flow cytometry

A unified definition of clinical resistance intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES

Combination therapy with interferon and JAK1-2 inhibitor is feasible: Proof of concept with rapid reduction in JAK2V617F-allele burden in polycythemia vera

Systemic adverse events following rituximab therapy in patients with Graves’ disease

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders

FRI0113 Rheumatoid arthritis and eosinophilia: the risk of lymphoproliferative malignancies and solid cancers. a study based on the copenhagen primary care differential count (copdiff) database

Angiogenesis in pulmonary hypertension with myelofibrosis

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera

Corrigendum to “Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera” [Leuk. Res. Rep. 3 (2) (2014) 73–75]

Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows

Echocardiographic signs of aortic valve dysfunction in patients with Philadelphia-negative myeloproliferative neoplasms

High JAK2V617F allele burden is associated with an increased burden of coronary artery calcification in MPNs

Suchergebnisse filtern